Quick Answer
Regencell Bioscience Holdings Ltd reported Total Assets of $5.76 million for the year ending 2025.
- Regencell Bioscience Holdings Ltd showed a decrease of -31.8% in Total Assets from 2024 to 2025.
- This data is from Regencell Bioscience Holdings Ltd's annual report (Form 10-K), filed with the SEC on October 31, 2025.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Regencell Bioscience Holdings Ltd's Total Assets has grown by 1,019.7%.
- Historical annual values: Fiscal year 2025: $5.76 million | Fiscal year 2024: $8.44 million | Fiscal year 2023: $12.62 million | Fiscal year 2022: $18.02 million | Fiscal year 2021: $340.1 thousand | Fiscal year 2020: $514.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: